查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1590849

糖化血紅素測試市場：按類型、方法和最終用戶分類 - 2025-2030 年全球預測

Glycated Hemoglobin Testing Market by Type (Laboratory Based Tests, Point-Of-Care Test), Technique (Boronate Affinity Chromatography, Direct Enzymatic Assay, High-Performance Liquid Chromatography), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年糖化血紅素檢測市值為6.8636億美元，預計到2024年將達到7.5413億美元，複合年成長率為9.96%，預計到2030年將達到13.3483億美元。

糖化血紅蛋白測試（通常稱為 HbA1c 測試）透過測量平均血糖值（通常在 2-3 個月內）在糖尿病管理中發揮至關重要的作用。此測試對於診斷和監測糖尿病、確定治療策略以及降低併發症的風險極為重要。全球糖尿病和糖尿病前期盛行率的不斷上升凸顯了其需求，導致其應用不僅在醫院和診斷實驗室，而且在居家照護環境中不斷擴大。最終用途包括糖尿病患者、醫療保健提供者，甚至尋求先進糖尿病管理策略的研究機構。影響成長的關鍵因素包括醫療保健支出增加、檢測方法的技術進步、消費者對糖尿病護理意識的提高以及政府的支持政策。隨著市場的發展，就地檢驗設備的整合和遠端醫療解決方案的發展帶來了潛在的機會，以滿足對方便、及時的診斷不斷成長的需求。為了抓住這些機會，公司應該專注於開發方便用戶使用且具有成本效益的測試解決方案，並利用數位平台進行更廣泛的推廣和資料整合。然而，監管限制、先進測試技術的高成本以及新興市場意識的缺乏等限制因素給市場擴張帶來了挑戰。此外，對現場護理設備準確性的擔憂可能會阻礙市場接受度。因此，技術創新應著重於提高檢測精度、降低成本、開發非侵入性檢測技術。市場本質上是動態的，其特點是技術不斷進步和競爭激烈，領先企業努力創新並贏得市場佔有率。隨時了解消費者需求和監管趨勢可以幫助相關人員克服挑戰，並為成長鋪平道路，以在糖化血紅蛋白測試市場取得持續成功。

主要市場統計
基準年[2023] 68636萬美元
預測年份 [2024] 75413萬美元
預測年份 [2030] 1,334.83百萬美元
複合年成長率（%） 9.96%

市場動態：快速發展的糖化血紅蛋白測試市場的關鍵市場洞察

供需的動態交互作用正在改變糖化血紅蛋白檢測市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 糖尿病等各種慢性病的全球盛行率不斷上升
    • 由於人口老化加劇，人們更容易罹患疾病
    • 快速採用患者自我護理解決方案
  • 市場限制因素
    • 糖化血紅素檢測設備的高成本
  • 市場機會
    • 家庭醫療保健市場的需求不斷成長，包括快速診斷測試和 PCOT
    • 持續進行早期診斷和有效疾病管理的研究和開發活動
  • 市場挑戰
    • HbA1c 檢測的限制和替代方案的可用性

波特五力：駕馭糖化血紅素測試市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解糖化血紅素測試市場的外部影響

外部宏觀環境因素在塑造糖化血紅蛋白測試市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解糖化血紅素檢測市場的競爭狀況

糖化血紅素測試市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣糖化血紅素檢測市場供應商的績效評估

FPNV定位矩陣是評估糖化血紅素檢測市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製糖化血紅蛋白測試市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，糖化血紅蛋白測試市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 在世界範圍內，糖尿病等各種慢性疾病的發生率正在增加。
      • 老年人口的增加導致疾病的脆弱性增加
      • 患者自我護理解決方案迅速普及
    • 抑制因素
      • 糖化血紅素檢測設備的高成本
    • 機會
      • 家庭醫療保健市場的新需求包括快速診斷測試和PCOT
      • 持續進行早期診斷和有效疾病管理的研究和開發活動
    • 任務
      • HbA1c 檢測的限制和替代方案的可用性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章糖化血紅蛋白測試市場：按類型

  • 基於實驗室的測試
  • 照護現場測試

第7章糖化血紅素測試市場：依技術分類

  • 硼酸鹽親和層析法
  • 直接酶測定
  • 高效液相層析
  • 免疫檢測

第 8 章 糖化血紅素測試市場：依最終用戶分類

  • 學術研究所
  • 診斷中心
  • 醫院

第9章 北美、南美糖化血紅素檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區糖化血紅素檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲糖化血紅素檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • A. Menarini Diagnostics srl
  • Abbott Laboratories Inc.
  • ARKRAY, Inc.
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • Daiichi Biotech Services Sdn. Bhd.
  • Danaher Corporation
  • DiaSys Diagnostic Systems GmbH
  • Diazyme Laboratories, Inc.
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche AG
  • Sebia
  • Siemens AG
  • TaiDoc Technology Corporation
  • Tosoh Corporation
  • Trinity Biotech
Product Code: MRR-4349B3591E79

The Glycated Hemoglobin Testing Market was valued at USD 686.36 million in 2023, expected to reach USD 754.13 million in 2024, and is projected to grow at a CAGR of 9.96%, to USD 1,334.83 million by 2030.

Glycated hemoglobin testing, often referred to as HbA1c testing, plays a pivotal role in diabetes management by measuring average blood glucose levels over a period, typically 2-3 months. This test is crucial for diagnosing and monitoring diabetes, guiding therapeutic decisions, and reducing the risk of complications. Its necessity is underscored by the increasing global prevalence of diabetes and prediabetes, thus expanding its application not only in hospitals and diagnostic labs but also in home-care settings. The end-use scope encompasses individuals with diabetes, healthcare providers, and even research institutions exploring advanced diabetes management strategies. Key influencing growth factors include rising healthcare expenditure, technological advancements in testing methods, increased consumer awareness regarding diabetic care, and supportive governmental policies. As the market evolves, potential opportunities arise from the integration of point-of-care testing devices and the growth of telemedicine solutions, which align with the increasing demand for convenient and timely diagnostics. To seize these opportunities, businesses should focus on developing user-friendly, cost-effective testing solutions and leverage digital platforms for wider outreach and data integration. However, limitations such as regulatory constraints, high costs associated with advanced testing technologies, and a lack of awareness in developing regions pose challenges to market expansion. Additionally, accuracy concerns with point-of-care devices can impede market acceptance. Innovation should therefore focus on enhancing test accuracy, reducing costs, and developing non-invasive testing techniques. The market is inherently dynamic, characterized by continuous technological progression and intense competition, with major players striving to innovate and capture market share. By staying attuned to consumer needs and regulatory developments, stakeholders can navigate challenges and leverage growth avenues for sustained success in the glycated hemoglobin testing market.

KEY MARKET STATISTICS
Base Year [2023] USD 686.36 million
Estimated Year [2024] USD 754.13 million
Forecast Year [2030] USD 1,334.83 million
CAGR (%) 9.96%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Glycated Hemoglobin Testing Market

The Glycated Hemoglobin Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of various chronic diseases such as diabetes globally
    • Rising geriatric population leads to higher vulnerability for diseases
    • Rapid adoption attributed to patient self-care solutions
  • Market Restraints
    • High cost pertinent to glycated hemoglobin testing equipment
  • Market Opportunities
    • Emerging demand for home healthcare market such as rapid diagnostic tests and PCOT
    • Ongoing R&D activities for early diagnosis and efficient disease management
  • Market Challenges
    • Limitation of HbA1c tests and availability of substitutes

Porter's Five Forces: A Strategic Tool for Navigating the Glycated Hemoglobin Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Glycated Hemoglobin Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Glycated Hemoglobin Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Glycated Hemoglobin Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Glycated Hemoglobin Testing Market

A detailed market share analysis in the Glycated Hemoglobin Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Glycated Hemoglobin Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Glycated Hemoglobin Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Glycated Hemoglobin Testing Market

A strategic analysis of the Glycated Hemoglobin Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Glycated Hemoglobin Testing Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Diagnostics s.r.l, Abbott Laboratories Inc., ARKRAY, Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Daiichi Biotech Services Sdn. Bhd., Danaher Corporation, DiaSys Diagnostic Systems GmbH, Diazyme Laboratories, Inc., EKF Diagnostics Holdings plc, F. Hoffmann-La Roche AG, Sebia, Siemens AG, TaiDoc Technology Corporation, Tosoh Corporation, and Trinity Biotech.

Market Segmentation & Coverage

This research report categorizes the Glycated Hemoglobin Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Laboratory Based Tests and Point-Of-Care Test.
  • Based on Technique, market is studied across Boronate Affinity Chromatography, Direct Enzymatic Assay, High-Performance Liquid Chromatography, and Immunoassay.
  • Based on End-User, market is studied across Academic & Research Institutes, Diagnostic Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of various chronic diseases such as diabetes globally
      • 5.1.1.2. Rising geriatric population leads to higher vulnerability for diseases
      • 5.1.1.3. Rapid adoption attributed to patient self-care solutions
    • 5.1.2. Restraints
      • 5.1.2.1. High cost pertinent to glycated hemoglobin testing equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging demand for home healthcare market such as rapid diagnostic tests and PCOT
      • 5.1.3.2. Ongoing R&D activities for early diagnosis and efficient disease management
    • 5.1.4. Challenges
      • 5.1.4.1. Limitation of HbA1c tests and availability of substitutes
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Glycated Hemoglobin Testing Market, by Type

  • 6.1. Introduction
  • 6.2. Laboratory Based Tests
  • 6.3. Point-Of-Care Test

7. Glycated Hemoglobin Testing Market, by Technique

  • 7.1. Introduction
  • 7.2. Boronate Affinity Chromatography
  • 7.3. Direct Enzymatic Assay
  • 7.4. High-Performance Liquid Chromatography
  • 7.5. Immunoassay

8. Glycated Hemoglobin Testing Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Diagnostic Centers
  • 8.4. Hospitals

9. Americas Glycated Hemoglobin Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Glycated Hemoglobin Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Glycated Hemoglobin Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. A. Menarini Diagnostics s.r.l
  • 2. Abbott Laboratories Inc.
  • 3. ARKRAY, Inc.
  • 4. Beckman Coulter, Inc.
  • 5. Bio-Rad Laboratories, Inc.
  • 6. Daiichi Biotech Services Sdn. Bhd.
  • 7. Danaher Corporation
  • 8. DiaSys Diagnostic Systems GmbH
  • 9. Diazyme Laboratories, Inc.
  • 10. EKF Diagnostics Holdings plc
  • 11. F. Hoffmann-La Roche AG
  • 12. Sebia
  • 13. Siemens AG
  • 14. TaiDoc Technology Corporation
  • 15. Tosoh Corporation
  • 16. Trinity Biotech

LIST OF FIGURES

  • FIGURE 1. GLYCATED HEMOGLOBIN TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. GLYCATED HEMOGLOBIN TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. GLYCATED HEMOGLOBIN TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GLYCATED HEMOGLOBIN TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GLYCATED HEMOGLOBIN TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY LABORATORY BASED TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY POINT-OF-CARE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY BORONATE AFFINITY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY DIRECT ENZYMATIC ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM GLYCATED HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. GLYCATED HEMOGLOBIN TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. GLYCATED HEMOGLOBIN TESTING MARKET, FPNV POSITIONING MATRIX, 2023